Takayasu, Kenta, Koei Muguruma, and Hidefumi Kinoshita. 2022. “Durable Complete Response to Combination Nivolumab and Ipilimumab in Metastatic Renal Cell Carcinoma”. Trends in Immunotherapy 6 (1). https://doi.org/10.24294/ti.v6.i1.1387.